BRONLIVAL EASYHALER

Glucocorticoid/ Beta-2 Adrenergic Agonist

Formoterol Fumarate - Budesonide

Composition

Bronlival Easyhaler 160/4,5 powder for oral inhalation
Each dose of BRONLIVAL Easyhaler 160 / 4.5 inhaling powder contains:
Budesonide 160 mcg
Formoterol fumarate dihydrate 4.5 mcg
Excipients: q.s.

Bronlival Easyhaler 320/9 powder for oral inhalation
Each dose of BRONLIVAL Easyhaler 320/9 inhalation powder contains:
Budesonide 320 mcg
Formoterol fumarate dihydrate 9 mcg
Excipients: q.s.

Presentations

Package of 160/4,5 per 120 doses
Package of  320/9 per 60 doses

Indications

Asthma:
BRONLIVAL Easyhaler is indicated in adults and adolescents from 12 to 17 years of age for usual treatment of asthma, when it is appropriate to use a combination (an inhaled corticosteroid and a long-acting β2-adrenergic agonist) in the following cases:
- Patients that are not adequately controlled with inhaled corticosteroids and short-acting inhaled ß2-adrenergic agonists "on demand".
- Patients who are adequately controlled with inhaled corticosteroids and long-acting ß2-adrenergic agonists.

COPD:
In adults over 18 years of age, BRONLIVAL Easyhaler is indicated for the symptomatic treatment of patients with severe chronic obstructive pulmonary disease (COPD) (FEV1 <50% of normal values), and a history of repeated exacerbations, who present significant symtoms in spite of being under usual treatment with long-acting bronchodilators.